ACAD
31.936
+0.496
+1.5782%
AEMD
1.517
+0.097
+6.8380%
APRI
1.516
+0.036
+2.4392%
ARNA
21.12
+0.1
+0.48%
ATEC
1.916
-0.004
-0.208%
CNAT
5.22
+0.04
+0.77%
CRXM
0.172
0.00
0.00%
CYTX
0.318
-0.003
-0.837074%
DXCM
75.51
-0.4
-0.53%
GNMK
9.52
+0.08
+0.85%
HALO
12.1
0.00
0.00%
ILMN
192.78
-1.98
-1.02%
INNV
0.112
-0.005
-4.1026%
INO
5.615
+0.055
+0.989%
ISCO
1.2
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
127.415
-0.555
-0.434%
LPTN
2.93
-2.93
-100.00%
MBVX
0.481
-0.029
-5.6078%
MEIP
2.554
-0.026
-1.0116%
MNOV
5.08
+0.03
+0.59%
MRTX
5.025
-0.275
-5.189%
MSTX
0.13
-0.01
-5.28%
NBIX
52.11
-0.55
-1.04%
NUVA
63.71
-0.99
-1.53%
ONCS
0.93
-0.01
-1.0532%
ONVO
1.889
-0.061
-3.128%
OREX
2.38
+0.04
+1.71%
OTIC
20.275
-0.075
-0.369%
QDEL
33.205
-0.275
-0.8220%
RCPT
231.96
0.00
0.00%
RGLS
0.918
+0.058
+6.6860%
RMD
74.035
-0.515
-0.691%
SCIE
0
0.00
0.00%
SPHS
1.92
+0.03
+1.59%
SRNE
1.65
-0.05
-2.94%
TROV
0.834
-0.017
-1.9412%
VICL
2.33
-0.04
-1.69%
VOLC
18
0.00
0.00%
ZGNX
12.55
+0.1
+0.80%
ACAD
31.936
+0.496
+1.5782%
AEMD
1.517
+0.097
+6.8380%
APRI
1.516
+0.036
+2.4392%
ARNA
21.12
+0.1
+0.48%
ATEC
1.916
-0.004
-0.208%
CNAT
5.22
+0.04
+0.77%
CRXM
0.172
0.00
0.00%
CYTX
0.318
-0.003
-0.837074%
DXCM
75.51
-0.4
-0.53%
GNMK
9.52
+0.08
+0.85%
HALO
12.1
0.00
0.00%
ILMN
192.78
-1.98
-1.02%
INNV
0.112
-0.005
-4.1026%
INO
5.615
+0.055
+0.989%
ISCO
1.2
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
127.415
-0.555
-0.434%
LPTN
2.93
-2.93
-100.00%
MBVX
0.481
-0.029
-5.6078%
MEIP
2.554
-0.026
-1.0116%
MNOV
5.08
+0.03
+0.59%
MRTX
5.025
-0.275
-5.189%
MSTX
0.13
-0.01
-5.28%
NBIX
52.11
-0.55
-1.04%
NUVA
63.71
-0.99
-1.53%
ONCS
0.93
-0.01
-1.0532%
ONVO
1.889
-0.061
-3.128%
OREX
2.38
+0.04
+1.71%
OTIC
20.275
-0.075
-0.369%
QDEL
33.205
-0.275
-0.8220%
RCPT
231.96
0.00
0.00%
RGLS
0.918
+0.058
+6.6860%
RMD
74.035
-0.515
-0.691%
SCIE
0
0.00
0.00%
SPHS
1.92
+0.03
+1.59%
SRNE
1.65
-0.05
-2.94%
TROV
0.834
-0.017
-1.9412%
VICL
2.33
-0.04
-1.69%
VOLC
18
0.00
0.00%
ZGNX
12.55
+0.1
+0.80%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.

Be Sociable, Share!